The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNPSN.L Regulatory News (NPSN)

  • There is currently no data for NPSN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

26 Oct 2021 16:15

RNS Number : 3214Q
Prosus NV
26 October 2021
 

Prosus N.V.

(Incorporated in the Netherlands)

(Legal Entity Identifier: 635400Z5LQ5F9OLVT688)

AEX and JSE Share Code: PRX ISIN: NL0013654783

(Prosus)

 

Update on PROSUS share REPURCHASE

Prosus today announces an update to its share repurchase programme of Prosus ordinary shares N (the Share Repurchase) announced on 23 August 2021.

As part of the Share Repurchase, for the period between 18 October 2021 and 22 October 2021, Prosus repurchased 2 684 168 Prosus ordinary shares N at an average price of €76.8055 per share for a total consideration of €206 158 792.83 (US$239 739 773.52).

More information on the Share Repurchase is available on https://www.prosus.com/news/investors-shareholder-information/.

Amsterdam, the Netherlands

26 October 2021

JSE sponsor to Prosus

Investec Bank Limited

 

 

Enquiries

Investor Enquiries

Eoin Ryan, Head of Investor Relations

+1 347-210-4305

Media Enquiries

Sarah Ryan, International Media Relations

+ 31 6 29721038

 

About Prosus

 

Prosus is a global consumer internet group and one of the largest technology investors in the world. Operating and investing globally in markets with long-term growth potential, Prosus builds leading consumer internet companies that empower people and enrich communities.

 

The group is focused on building meaningful businesses in the online classifieds, food delivery, payments and fintech, and education technology sectors in markets including India, Russia and Brazil. Through its ventures team, Prosus invests in areas including health, logistics, blockchain, and social commerce. Prosus actively seeks new opportunities to partner with exceptional entrepreneurs who are using technology to improve people's everyday lives.

 

Every day, millions of people use the products and services of companies that Prosus has invested in, acquired or built, including Avito, Brainly, BYJU'S, Bykea, Codecademy, DappRadar, DeHaat, dott, ElasticRun, eMAG, Eruditus, Honor, iFood, Klar, LazyPay, letgo, Meesho, Movile, OLX, PayU, Quick Ride, Red Dot Payment, Remitly, Republic, SimilarWeb, Shipper, Skillsoft, SoloLearn, Swiggy, and Udemy.

 

Hundreds of millions of people have made the platforms of Prosus's associates a part of their daily lives. For listed companies where we have an interest, please see: Tencent (www.tencent.com), Mail.ru (www.corp.mail.ru), Trip.com Group Limited (www.trip.com), and DeliveryHero (www.deliveryhero.com).

Today, Prosus companies and associates help improve the lives of around a fifth of the world's population.

 

Prosus has a primary listing on Euronext Amsterdam (AEX:PRX) and secondary listings on the Johannesburg Stock Exchange (XJSE:PRX) and a2X Markets (PRX.AJ). Prosus is majority owned by Naspers. For more information, please visit www.prosus.com.

 

Disclaimer

 

The Programme is being conducted in accordance with Articles 5(1) and 5(3) of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse ("Market Abuse Regulation") and Articles 2 to 4 of Commission Delegated Regulation (EU) 2016/1052 supplementing the Market Abuse Regulation with regard to regulatory technical standards for the conditions applicable to buy-back programmes and stabilisation measures (the "Delegated Regulation"). This document is issued in connection with the disclosure and reporting obligation set out in Article 2(1) of the Delegated Regulation.

This document contains information that qualifies as inside information within the meaning of Article 7(1) of the Market Abuse Regulation.

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

The information contained in this announcement may contain forward-looking statements, estimates and projections. Forward-looking statements involve all matters that are not historical and may be identified by the words "anticipate", "believe", "estimate", "expect", "intend", "may", "should", "will", "would" and similar expressions or their negatives, but the absence of these words does not necessarily mean that a statement is not forward-looking. These statements reflect Prosus's intentions, beliefs or current expectations, involve elements of subjective judgement and analysis and are based upon the best judgement of Prosus as of the date of this announcement, but could prove to be wrong. These statements are subject to change without notice and are based on a number of assumptions and entail known and unknown risks and uncertainties. Therefore, you should not rely on these forward-looking statements as a prediction of actual results. 

Any forward-looking statements are made only as of the date of this announcement and neither Prosus nor any other person gives any undertaking, or is under any obligation, to update these forward-looking statements for events or circumstances that occur subsequent to the date of this announcement or to update or keep current any of the information contained herein, any changes in assumptions or changes in factors affecting these statements and this announcement is not a representation by Prosus or any other person that they will do so, except to the extent required by law.

.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFLVIELRFIL
Date   Source Headline
3rd Aug 201712:00 pmRNSCOMPETITION TRIBUNAL APPROVAL MEDIA24 NOVUS MERGER
2nd Aug 20172:00 pmRNSADR RATIO CHANGE
21st Jul 20173:11 pmRNSDirector/PDMR Shareholding
21st Jul 20171:00 pmRNSAnnual Financial Report
11th Jul 20174:56 pmRNSDirector/PDMR Shareholding
5th Jul 20174:50 pmRNSDirector/PDMR Shareholding
30th Jun 20177:30 amRNSBOND OFFERING BY MYRIAD - PRICING
23rd Jun 20172:00 pmRNSFinal Results
22nd Jun 20179:00 amRNSPOSSIBLE USD BOND OFFERING
14th Jun 20174:55 pmRNSTrading Statement
3rd Apr 201711:06 amRNSUPDATE ON MEDIA24 COMPETITION APPEAL COURT RULING
31st Mar 20173:29 pmRNSDirectorate Change
15th Mar 20172:06 pmRNSDirector/PDMR Shareholding
24th Feb 20172:30 pmRNSDirector/PDMR Shareholding
7th Feb 20172:21 pmRNSDirector/PDMR Shareholding
3rd Feb 20171:00 pmRNSNOTIFICATION s 122(3) OF THE CO ACT & s3.83(b) JSE
31st Jan 201712:00 pmRNSClosing of the ibibo/MakeMyTrip transaction
19th Jan 20172:01 pmRNSDirector/PDMR Shareholding
18th Jan 201711:30 amRNSClosing of the Allegro transaction
18th Jan 20177:14 amRNSNOTIFICATION IN TERMS OF S122(3) SA CO ACT
4th Jan 20172:30 pmRNSDirector/PDMR Shareholding
19th Dec 20163:00 pmRNSDirector/PDMR Shareholding
5th Dec 20163:30 pmRNSDirector/PDMR Shareholding
25th Nov 20162:00 pmRNSHalf-year Report
18th Nov 201612:20 pmRNSTrading Statement
18th Oct 20162:45 pmRNSMakeMyTrip Limited and Ibibo group to combine
14th Oct 20163:00 pmRNSDisposal
31st Aug 20164:30 pmRNSDirector/PDMR Shareholding
26th Aug 20164:00 pmRNSAGM Statement
22nd Jul 20162:30 pmRNSNotice of AGM
14th Jul 20164:09 pmRNSDirector/PDMR Shareholding
6th Jul 20164:01 pmRNSDirector/PDMR Shareholding
24th Jun 20165:00 pmRNSFinal Results
15th Jun 20162:00 pmRNSTrading Statement
13th Jun 20163:00 pmRNSNotice in terms of S122 of SA Companies Act
18th Apr 20164:00 pmRNSChange in reporting currency
31st Mar 20164:00 pmRNSDirector/PDMR Shareholding
31st Mar 20164:00 pmRNSDirector/PDMR Shareholding
15th Mar 20166:03 pmRNSADR ratio change and distribution
10th Mar 201612:31 pmRNSDirector/PDMR Shareholding
24th Feb 20163:12 pmRNSNOTIFICATION IN TERMS OF S122(3) OF THE CO ACT
29th Jan 20162:59 pmRNSDirectorate Change
26th Jan 20163:09 pmRNSDirector/PDMR Shareholding
26th Jan 201612:34 pmRNSDirector/PDMR Shareholding
20th Jan 20161:58 pmRNSCorrection to S122 notification just released
20th Jan 20161:36 pmRNSS122 of the SA Companies Act notification
30th Dec 20153:05 pmRNSDirector/PDMR Shareholding
29th Dec 20157:15 amRNSDirector/PDMR Shareholding
24th Dec 201510:05 amRNSDirector/PDMR Shareholding
18th Dec 20153:05 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.